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Renal pelvic neoplasms and atypical urothelium in patients with
end-stage analgesic nephropathy
INGEMAR BLOHME arid SONNY JOHANSSON
Departments of Surgery and Pathology, Sahigren s Hospital, University ofGOteborg, Goteborg, Sweden
Renal pelvic neoplasms and atypical urothelium in patients with end-
stage analgesic nephropathy. In a series of 772 renal transplant patients,
84 had analgesic nephropathy (AN). Four of them had renal pelvic
carcinoma. The incidence of atypical urothelial changes of the renal
pelvis was studied in 56 AN patients, the majority nephrectomized
before or shortly after the renal transplantation. Urothelial atypia,
usually bilaterally, was found in 27 patients. Multiple sections resulted
in an even higher incidence (8/9). No atypical changes were found in
normal kidneys or in end-stage diseased kidneys with other diseases, or
in chronically rejected renal allografts. These findings further strength-
en the association between intake of phenacetin-containing analgesics
and the development of renal pelvic tumors. Patients with end-stage
analgesic nephropathy are a high-risk group for developing urinary tract
tumors and should be subjected to endoscopic and cytologic surveil
lance. After renal transplantation, prophylactic bilateral nephroureter-
ectomy is advocated.
Néoplasmes pyeliques et épithélium urinaire atypique chez des malades
atteints de néphropathie des analgesiques (AN) au stade terminal. Dans
une série de 772 malades traités par transplantation rénale, 84 avaienl
une AN. Quatre d'entre eux avaient un carcinome pyelique. La
frequence d'atypies de l'épithélium urinaire a été étudiée chez 56
malades atteints d'AN dont Ia majorité a subi une néphrectomie avant
ou peu aprés Ia transplantation rénale. Des atypies de l'épithélium
urinaire ont été trouvées dans 27 cas, habituellement bilatérales. Des
coupes en shrie ont méme montré une fréquence plus grande (8/9). Ces
modifications n'ont pas été observées dans des reins normaux ou dans
d'autres affections rénales au stade terminal, ou encore dans des series
de rejet chronique. Ces constatations renforcent encore l'association
entre l'ingestion d'analgesiques contenant de Ia phenacetine et le
développement de tumeurs pyeliques. Les malades atteints d'AN au
stade terminal ont des risques élevés de tumeur de l'appareil urinaire et
doivent être soumis a une surveillance endoscopique et cytologique.
Apres transplantation, Ia nephrectomie bilatérale prophylactique est
recommandée.
The association between heavy abuse of phenacetin-contain-
ing analgesics and the development of renal pelvic tumors was
first reported from Sweden by Hultengren, Lagergren, and
Ljungqvist [1]. More than 100 such cases have appeared in the
literature, most of them reported from Sweden [21. Lately there
is, however, an increasing number from other parts of the world
[3—6]. Tumors of the urinary bladder and ureter have also been
reported in phenacetin abusers [6, 7]. The majority of these
patients had, in addition to their tumor disease, chronic intersti-
tial nephritis, and renal papillary necrosis.
The incidence of renal disease associated with drug abuse
decreased markedly when the 'over-the-counter" sale of phen-
acetin was stopped in Sweden in 1961. Furthermore, in patients
whose renal function was already impaired, the cessation of
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drug abuse resulted in a slower progression of the nephropathy
to terminal renal failure [2, 8]. In contrast, an increasing number
of renal pelvic tumors have been reported [9].
The induction times for renal pelvic and urinary bladder
malignancies associated with abuse of phenacetin-containing
drugs have been calculated to be 22 and 29 years, respectively
[7, 10]. Similar induction times have been reported for other
chemically induced bladder cancers [11].
Tumor development in the urinary tract has been suggested
to be a continuous process, which includes transition from
normal epithelium to atypical epithelium, carcinoma in situ, and
invasive carcinoma [12]. Renal pelvic tumors, whether associat-
ed with phenacetin abuse or not, have a strong tendency to
occur multifocally, either concurrently or sequentially [10, 13].
Considering these circumstances, not only urothelial neoplasms
but also urothelial atypia should be expected to occur among
hemodialysis and renal transplant patients with analgesic
nephropathy.
The objective of the present investigation was to study the
occurrence of urothelial atypia in patients with end-stage anal-
gesic nephropathy, derived from a renal transplant series. In
addition four such patients with renal pelvic cancer are report-
ed.
Methods
Between 1965 and 1979, 1079 renal transplants were per-
formed on 772 patients with terminal renal failure at the Surgical
Clinic I, Sahigren's Hospital, Goteborg, as reported previously
in some detail by Gelin et a! [14]. The renal diseases leading to
terminal failure in these patients were: chronic glomerulone-
phritis (44%), chronic pyelonephritis/interstitial nephritis
(27%), polycystic kidney disease (13%), and other diseases
(16%). Among the patients with chronic pyelonephritis and
interstitial nephritis, 84 patients were classified as analgesic
abusers on the basis of a history of regular consumption of
phenacetin-containing analgesics (Table 1).
Fifty-six patients with analgesic nephropathy (AN) were
included in the study (group 1), excluding four patients with AN
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Table 1. Analgesic nephropathy (AN) in the Goteborg renal transplant
series
Year AN/total
1965—69 33/165 20.0
1970—72 23/186 12.4
1973—75 16/183 8.7
1976—79 12/238 5.0
Total 84/772 10.9
and renal pelvic tumors, reported separately below. The re-
maining 24 patients with AN were excluded because of lack of
histologic material, or because only autopsy material was
available for analysis. Autolysis of the urotheliurn prevented
the use of autopsy material for the present purpose.
To group IA were allocated 47 patients who had undergone
nephrectomy during the past 14 years and whose paraffin blocks
could be re-collected. These often contained rather sparse
material from the urothelium. In 44 of these patients, material
from both kidneys was available for study. Two hundred and
eighty-one histologic sections were studied from these 91
kidneys, which gives an average of 5.9 sections per patient
(range, 3 to 8).
The last nine patients (group IB) joined the study during
1978—79, and abundant material from the ureter and renal pelvis
was secured by multiple sections. Both kidneys were available
in live patients, one kidney in four. i'wo hundred and eighty
sections were studied with a mean of 31 .1 sections per patient
(range, 16 to 38).
Group 2 consisted of 15 patients with chronic nonobstructive
pyelonephritis (PN) without history or histopathologic evidence
of analgesic abuse. Both kidneys were available in 13 patients.
One hundred and eight sections were studied with a mean of 7.2
sections per patient (range, 4 to 14).
Group 3 consisted of 15 patients with chronic glomerulone-
phritis (GN). Both kidneys were available from 12. Sixty-eight
sections were studied with a mean of 4.5 sections per patient
(range, 2 to 10).
Group 4 consisted of 11 renal allografts having failed from
slow chronic rejection, 3 to 10 years after transplantation. The
number of sections studied was 68 (mean, 6.1 per patient;
range, 3 to 10).
Group 5 consisted of the kidneys from 15 patients without
evidence of renal disease, mostly discarded cadaveric kidneys.
Both kidneys were examined in three patients. Two hundred
and fifty-six sections were studied (mean 17,1 per patient;
range, 8 to 34).
Histologic method. Paraffin blocks from all cases were col-
lected and new 5-pm sections were stained with hematoxylin
and eosin, according to Weigert and van Gieson. The urothe-
hum was arbitrarily graded as showing no atypia or mild,
moderate, or severe atypia, the latter corresponding to carcino-
ma in situ (Figs. 1—3).'
In a preliminary study, the renal pelvic urothelium and renal
parenchyma were examined together. In a second study, see-
'A similar grading of flat atypical renal pelvic lesions was recently
reported by Lomax-Smith and Seymour [231.
tions were prepared to contain only renal pelvic mucosa and/or
proximal ureter. Thus, a total number of 1061 sections were
examined blindly, distributed in the different study groups as
reported above. All sections in both studies were assessed by
the same pathologist.
Age and sex. Among the patients with analgesic nephrop-
athy, 19 were males and 37 females. The mean age at nephrecto-
my was 47 years (range, 32 to 60) in group IA and 55 years (46
to 61) in group lB.
In group 2 (with PN), 4 patients were males and II females.
The mean age was 50 (38 to 61) years. Among the patients of
group 4 (with GN), 10 were males and 5 females. The mean age
was 47 (38 to 58) years. In group 4 nine kidney donors were
males, two females. The mean donor age at nephrectomy
including duration of graft in the recipient was 45 years (range,
18 to 65). In group 5, six patients were males and nine females.
The mean age was 51(30 to 71) years.
Duration of renal disease and of immunosuppressive thera-
py. The documented duration of renal disease in the AN group
varied between less than 1 year and more than 30 years, Many
cases of advanced uremia had appeared, the duration of disease
not being possible to assess in half of the cases. In 18 patients of
group 1A, however, the duration of disease was probably less
than 5 years, whereas it exceeded with certainty 10 years in
nine patients. The duration of renal disease was long (10 to 30
years) in groups IB, 2, and 3.
A policy of routine bilateral nephrectomy was pursued up
until 1971. Thus, 26 AN kidneys had been removed before renal
transplantation, 22 during the first posttransplant year (12
within 3 months) and 8 kidneys I to 4 years later. Five of the
latter belonged to group lB. In group 2, seven patients were
nephrectomized before, seven during the first year after trans-
plantation, and one after more than 4 years. Seven group 3
patients were nephrectomized before, seven during the first
posttransplant year, and one after more than 2 years.
Group 4 kidneys (rejected allografts) were removed from
their recipients 3 to 10 years (mean, 6.1 years) after transplanta-
tion. Immunosuppressive therapy had continued throughout the
duration of the grafts.
Analgesic abuse. Because the present investigation was
mainly retrospective, it was not possible to calculate the exact
amount of drug ingested by the individual patient. The majority
of the patients had been taking a compound containing 0.5 g of
phenacetin, 0.5 g of phenazone, and 0.1 g of caffeine. The
overconsumption had usually taken place during the 1940—50
period and ceased in 1961, when phenacetin was put on
prescription, or somewhat earlier, so advised by the medical
profession, who by then was aware of this problem.
The nine prospectively studied cases (group IB) underwent
nephrectomy in 1978—79, an average of 30 years after the drug
abuse was started ("induction time"). The mean "induction
time" of the retrospectively studied group was about 8 years
shorter (range, 5 to 37 years).
Case reports. Among our 772 transplanted patients, four had
carcinoma of the renal pelvis. They all had a history of heavy
abuse of phenacetin-containing analgesics, and all had intersti-
tial nephritis with renal papillary necrosis, which in three
patients was ectopic bone formation. Two were diagnosed 3
months and 10 years, respectively, before transplantation,
whereas 2 appeared I year and 4 years after successful trans-
0
____
a .
—
';%.,. •• .-'lt._&s? !:;4'
•. lb0 ,I•s• :'.
,
4H ;i% '5.I b' .e!_ . a.—.e . ..
— — a P • a _
—— aS _— — •a a -
S
'
a • 's
— .
'.)'t' .i1t
• ••
,j$5 I;
---:; •s!__ \t 4
— —-
$ $ . ' S
. — q $1%,•$q1
S —' t.A, • a
S I SI5- -$ _t
__i.—'p S 'l
— S. —
I
Renal pelvic neoplasia and analgesic nephropa thy 673
plantation. Tumors were graded according to Bergquist et al
[151.
Case 1. A male patient, born 1910, was found to be uremic in
1970 (GFR, 14 mI/mm) when renal pelvic tumors and renal
papillary necrosis were diagnosed. Bilateral nephroureterec-
tomy revealed invasive grade-3 tumors with areas of carcinoma
in situ of the renal pelvis and also one cortical adenoma. He
received a cadaveric renal transplant after 3 months of hemodi-
alysis. Multiple grade-3 tumors occurred in the urinary bladder,
and he died from metastatic disease 10 months later.
Case 2. A female patient, born 1930, was found, in 1919
during a general health examination, to have moderately im-
paired renal function and microscopic hematuria. An invasrie
grade-3 renal pelvic tumor was removed by right radical neph-
roureterectomy. Ten years later, after 6 months of hemodialy-
sis, a successful cadaveric renal transplantation was performed.
The remaining kidney and ureter were removed and a noninva-
sive urothelial grade-i tumor was found in the renal pelvis,
along with areas of mild urothelial atypia. In addition three
cortical adenomas were found.
Case 3. A female patient, born 1925, was diagnosed in 1958 as
having RPN. She was started on hemodialysis in 1974 and
received a well-functioning cadaveric renal transplant after 2
years. One year later an explorative laparotomy revealed peritc-
neal carcinosis. At autopsy, a poorly differentiated squamous cell
carcinoma in the right renal pelvis was found, with multiple
bladder lesions, as well as wide spread distant metastases.
Case 4. A female, born 1926, was diagnosed in 1968 as having
RPN. In 1974, she received a cadaveric renal transplant before
hemodialysis had become necessary. The graft has functioned
normally since then. In 1978, a routine examination of urine
cytology indicated malignancy, and she was found to have
tumor growth in the left renal pelvis and ureter, protruding into
the urinary bladder. Bilateral nephroureterectoniy was per-
formed. The tumor was a grade-2 tumor with superficial inva-
sion. Carcinoma in situ was found in association with the pelvic
tumor, and moderate urothelial atypia was found in the contra-
lateral kidney. One year later, a small adenocarcinoma of the
transverse colon was resected. She is alive and well.
Results
The occurrence of analgesic nephropathy in the Goteborg
Renal Transplant Series is demonstrated in Table 1.
All patients classified as abusers had histologic evidence of
chronic interstitial nephritis and renal papillary necrosis. Ectop-
ic bone formation within necrotic renal papillae was found in
73% of the patients (Fig. 4). Renal papillary necrosis was found
in one patient with chronic pyelonephritis, no such lesion was
seen in the other groups.
Urothelial atypia was seen in 19/47 patients of group IA, and
in 8/9 cases of group lB (Table 2). Bilateral lesions were found
in 16 patients, all in group IA. In 14 patients, the atypia was
"moderate," and in 13 patients it was 'mild." The atypia was
often associated with urothelial hyperplasia. In addition, four
patients had small cortical adenomas, varying in size from 0.5 to
1.5 cm.
Urothelial atypia was not detected in any kidney from
patients with chronic pyelonephritis, chronic glomerulonephri-
tis, or in chronically rejected allografts or in normal kidneys.
One PN kidney contained a small cortical adenoma. The
Fig. 3. Hyperplastic moderate/v atypical ,irotheliu,n oft/ic renalpelvis
in a phenacetin abuser. H&E, x 133.
differences were tested statistically by use of two-sided Fisch-
er's exact test: Group IA vs. group lB or4, P <0.05: vs. group
2,3, or 5, P <0.01.
The blind study of the urothelium yielded identical results
compared with the preliminary open examination, except for 2
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(9/23 and 8/21, respectively). Two of three kidneys removed Ito
3 years later had atypical urothelium. In group 1B, 4 patients
were nephrectomized before (I was atypia negative) and 5
patients 1 to 4 years after transplantation. Altogether, 7/8 AN
patients nephrectomized more than 1 year posttransplant had
atypical urothelium. This difference did not reach statistical
significance (P = 0.07).
Discussion
Group
1A
lB
2
3
4
5
Patients
RPNb
(bone)
tirothelial
atypia
Histologic
sections/patient
no. no. no. mean (range)
47 47 (33) 19 5.9 (3 to 8)
9 9(8) 8 31.1 (16 to 38)
15 I — 7.2 (4to14)
15 — — 4.5 (2tolO)
11 — — 6.2 (3toIO)
15 — — 17.1 (8to34)
a Two-sided Fischer's exact test: IA vs. lB or 4 was P < 0,05; IA vs.
2,3, or 5 was P <0.01.
b RPN is renal papillary necrosis, with or without ectopic bone
formation.
patients, both in group IA. These were judged as normal in the
blind study but with mild atypia in the open one. These 2
patients were reexamined and the difference was, in one patient
due to a difference in evaluation, and in the other patient the
small atypical part of the urothelium had been removed along
with the underlying renal papilla. The latter was excepted as
atypia-positive.
The possible importance of patient age, duration of renal
disease, "induction time," and of posttransplant immunosup-
pressive state was analyzed, between studied groups and within
the AN group. There was no difference in patient age between
studied groups. In group IA, patients with and without atypia
had an almost identical mean age (47 and 48 years) and mean
"induction times" (23 years). Corresponding figures for group
lB were 55 and 30 years.
Patients of groups 2 and 3 all had documented long duration
of renal disease (10 to 30 years), whereas among AN patients
there were cases with long as well as very short durations.
Within group 1A, atypia was noted as often in cases with the
shortest duration as it was in those with long duration (9/18 and
4/9, respectively). All group lB patients had long duration of
renal disease.
Urothelial atypia was present in equal incidence in group lA
kidneys removed before and within 1 year after transplantation
Renal failure associated with abuse of phenacetin-containing
analgesics has become increasingly rare in Sweden, which is
also reflected in our transplant program (Table 1). In countries
where these drugs have remained easily accessible, analgesic
nephropathy continues to constitute up to 50% of patients with
terminal renal failure [3, 16, 171.
A serious complication of patients with analgesic nephrop-
athy is the occurrence of urinary tract neoplasms, The in-
creased incidence of such tumors in Sweden where the use of
phenacetin-containing analgesics was virtually stopped 20 years
ago may be explained by the long induction time of these
tumors along with prolonged survival of such patients. The
longer survival is the result of the cessation of drug abuse and
treatment with hemodialysis and/or renal transplantation.
From our renal transplant series, we report four cases of
renal pelvic carcinoma among 84 patients with analgesic
nephropathy (AN). With the exception of one small noninva-
sive urinary bladder papilloma, no other urothelial malignancy
occurred in our 688 transplant patients with other renal dis-
eases.
In the present study of the pelvic urothelium of kidneys
removed from 56 AN patients, atypical changes were present itt
about half of the cases and usually bilaterally. This contrasts
with the complete absence of urothelial atypia in normal
kidneys and in kidneys from patients with end-stage chronic
glomerulonephritis, chronic pyelonephritis, and in rejected re-
nal allografts.
The occurrence of urothelial atypia in AN patients and not in
controls could not be explained in terms of patient age, duration
of renal disease, or immunosuppressive therapy. Cigarette
smoking, which also is associated with urinary tract malignan-
cy, was certainly present in all groups, and most probably
overrepresented among phenacetin abusers. The possible im-
portance of this factor could, however, not be assessed in this
mainly retrospective study.
The reason for reporting the cases of group I B separately is
that these were examined in a prospective fashion, with multi-
ple histologic sections, and that the incidence of urothelial
atypia was even higher in this group. This small group had a
somewhat higher mean age, a longer duration of renal disease,
and also a longer "induction time." These factors did not,
however, seem to influence the incidence of urothelial atypia,
when tested on the retrospectively studied group IA. Thus,
there is reason to assume that the higher incidence of urothelial
atypia in group lB is due to the fact that these had been more
carefully examined. Consequently, atypical urothelium might
be expected to be present in the majority of patients with end-
stage analgesic nephropathy.
An increased incidence of malignant disease in renal trans-
plant recipients is well documented by individual centers, as
well as by special registries [18—20]. Although this has been due
Fig. 4. Ectopic bone formation with fatty marrow in a necrotic renal
papilla. H&E, x51.
Table 2. Urothelial atypia in end-stage analgesic nephropathy (group
1), chronic pyelonephritis (group 2), chronic glomerulonephritis
(group 3), in chronically rejected allografts (group 4) and in normal
controls (group 5)a
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mostly to the occurrence of malignant lymphomas, skin can-
cers, and noninvasive lesions of the uterine cervix, reports on
renal pelvic malignancies have been few and almost exclusively
in patients with analgesic nephropathy [211.
In this study the majority of kidneys had been removed from
the patients before transplantation (and immunosuppression),
or shortly thereafter. Among kidneys removed more than 1 year
after transplantation, atypical changes were seen in 7 out of 8
cases. It can not be completely ruled out that the impact of
transplantation might have contributed to this effect. But atypi
cal urotheliurn was not encountered in any transplanted and
chronically rejected renal allograft removed after up to 10 years
of immunosuppressive therapy.
The urothelial histopathology ranged from normal to increas-
ingly severe atypia. The grading of such changes is arbitrary
and might be suspected to be easily biased by the rather
characteristic appearance of renal pathology in analgesic
nephropathy. Therefore, in the present study, the first assess-
ment of the urothelium was supplemented with a blind analysis,
with the renal pelvic mucosa cut away from adjacent tissue. The
almost identical result of this blind study compared to the
preliminary open grading, should be reassuring as to the ade-
quacy of the method of assessment of the urothelium.
Does urothelial atypia represent a truly precancerous lesion
or is it merely an innocent abnormality? In favor of the former
view is the frequent finding of atypical changes in seemingly
disease-free urothelium in patients with bladder carcinoma, as
well as the multifocal and recurrent character of such lesions.
The different stages of atypical urothelium described in this
report might then represent steps towards the development of
malignancy.
The high incidence of urothelial atypia and the occurrence of
four malignant renal pelvic tumors in this series of patients with
end-stage analgesic nephropathy are significant and further
strengthen the association between abuse of phenacetin-con-
taming analgesics and the gradual development of neoplastic
lesions in the urinary tract. The findings of renal cell adenomas
among the phenacetin abusers is more difficult to evalute. Long
term administration of phenacetin to rats, however, is associat-
ed with the development of renal cell tumors [221.
The clinical implications of this association is obvious. It is
important to diagnose correctly analgesic nephropathy because
these patients are a high-risk group for developing urinary tract
tumors, especially in the renal pelvis. The urothelium of such
patients should be repeatedly examined by urinary cytology. To
obtain adequate material from the renal pelvis in patients
without urinary production and to exclude ureteral obstruction
by tumor or by shed renal papillae, it is necessary and feasible
to perform retrograd catheterization to obtain pyelogram and
washout of the renal pelvis (unpublished experience). Prophy-
lactic bilateral nephroureterectomy should be seriously consid-
ered in renal transplant patients with analgesic nephropathy.
For patients on chronic hemodialysis, the benefit of retained
kidneys in terms of urine and erythropoietin production might
justify a more conservative approach. The multifocal character
of these lesions necessitates the continued surveillance of the
urinary bladder even after radical surgery.
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